A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
Frost C, Song Y, Barrett YC, et al. Clin Pharmacol. 2014;6:179–187.
Page 183, Figure 2, the arithmetic mean apixaban trough concentration on Day 4 prior to the morning dose (ie, 0-hr Figure 2) was not correct. The arithmetic mean (SD) apixaban trough concentration on Day 4 prior to the morning dose was 24.6 (6.1) ng/mL.
Read the original article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]